Home / Diabetes In Control (page 383)

Diabetes In Control

DocbookMD

DocbookMD1

DocbookMD Free with membership iOS/Android    DocbookMD is an exclusive HIPAA-secure messaging application for smartphone and tablet devices. Designed by and for physicians it creates a secure community to share patient information and collaborate with medical colleagues. In the past year, DocbookMD has experienced incredible growth now counting nearly 20,000 …

Read More »

Letter from the Editor, #688

Over and over we have new therapies for diabetes come to the market with lots of promise and hope. These new classes with great results in pre-marketing studies offer extra armament to fight the epidemic of diabetes yet they don’t get used because of words like "cardiac arrest" and "cancer." …

Read More »

GLUCOCARD® Expression™

GLUCOCARD

With its large tactile buttons and fully audible features, the GLUCOCARD® Expression™ has quickly become a cost effective alternative for diabetic users with visual and/or hearing impairments. This talking meter, in both English and Spanish, has the most frequently requested features by both users and healthcare providers. Connecting to the ARK …

Read More »

FDA: Diabetes Test Strip Maker Recalls 62 Million Products

FDA: Diabetes Test Strip Maker Recalls 62 Million Products  Nova Diabetes Care announced it is initiating a voluntary recall of 21 lots of the Nova Max Glucose Test Strips distributed both in the USA and outside the continental USA. Nova Max® Plus™ Glucose meter kits are included in this recall. …

Read More »

Diabetes 1500 BC

Diabetes was one of the first diseases ever described when an Egyptian manuscript from 1500 BC mentioned "too great emptying of the urine." Indian physicians around the same time identified the disease and classified it as madhumeha or "honey urine," noting the urine would attract ants. Type 1 and type …

Read More »

Elderly Diabetes Sufferers More Likely to Have a Disability

Researchers trawled through more than 3,200 previously published studies exploring the link between diabetes and disability. Most people in the studies were over 65. Lead epidemiologist Anna Peeters said the association between diabetes and disability was long known and until now poorly identified but the causes remain mysterious. "It’s possible …

Read More »

Dapagliflozin Resubmitted to FDA

The FDA has acknowledged receipt of a resubmission of the new drug application (NDA) for dapagliflozin, an SGLT-2 inhibitor for the treatment of type 2 diabetes…. Astra Zeneca and Bristol-Myers Squibb (BMS) have announced that the agency has issued a new Prescription Drug User Fee Act goal date of January …

Read More »